Post by marriott on Dec 22, 2022 23:52:59 GMT
The patent expiration date for the Novavax Matrix-M Adjuvant, patent #10544399, is July 11, 2023.
This means that Matrix-M becomes part of the public domain , patent-related royalties may stop and and
patent-related licensing agreements will no longer be enforceable.
I sincerely hope the management team will work on making the NOVAVAX brand into something customers can understand, support, and even advocate for.
It won't be easy and I now believe the current team needs more effective leadership and talent to move forward with confidence and build trust with investors and stakeholders .
This means that Matrix-M becomes part of the public domain , patent-related royalties may stop and and
patent-related licensing agreements will no longer be enforceable.
I sincerely hope the management team will work on making the NOVAVAX brand into something customers can understand, support, and even advocate for.
It won't be easy and I now believe the current team needs more effective leadership and talent to move forward with confidence and build trust with investors and stakeholders .